AKT1 and prostate carcinoma: Dubrovska et al. [40] found that PTEN/PI3K/Akt pathway is critical for prostate cancer stem-like cell maintenance and that targeting PI3K signaling may be beneficial in prostate cancer treatment by eliminating prostate cancer stem-like cells.